MDT Earnings Expected to Rise 19.23% to $1.55/share on May 25
AI Robots: Trading in Every Style
Medical Device Technologies (MDT) is set to release its quarterly earnings report on May 25, and analysts are anticipating a significant increase in earnings per share. According to market forecasts, MDT's earnings are expected to rise by an impressive 19.23%, reaching $1.55 per share.
This projected growth in earnings comes as a positive sign for MDT and its investors. It indicates that the company's financial performance is improving, potentially reflecting successful business strategies and increased demand for its medical devices.
MDT operates in the highly competitive and ever-evolving healthcare industry, specializing in the development and production of cutting-edge medical technologies. As the healthcare sector continues to expand and technological advancements drive innovation, companies like MDT have the opportunity to capitalize on the growing demand for their products.
The anticipated increase in earnings per share suggests that MDT has managed to maintain or expand its market share while delivering strong financial results. This could be attributed to various factors, such as successful product launches, effective cost management, or strategic acquisitions.
Investors will be closely monitoring MDT's earnings report to gauge the company's financial health and growth prospects. Positive earnings results could potentially lead to increased investor confidence and subsequent stock price appreciation. On the other hand, disappointing earnings could have the opposite effect, causing investors to reevaluate their positions in the company.
It is important to note that while earnings projections provide valuable insights, actual financial performance may vary. Various internal and external factors can influence a company's earnings, including market conditions, regulatory changes, competition, and global economic trends. Therefore, investors should consider multiple factors and conduct thorough research before making any investment decisions.
As May 25 approaches, market participants will be eagerly awaiting MDT's earnings announcement. The company's ability to meet or exceed expectations could have a significant impact on its stock performance and investor sentiment.
MDT's Stochastic Oscillator is sitting in oversold zone for 4 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDT advanced for three days, in of 328 cases, the price rose further within the following month. The odds of a continued upward trend are .
MDT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 245 cases where MDT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on May 22, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MDT as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for MDT turned negative on May 22, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
MDT moved below its 50-day moving average on May 21, 2025 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for MDT moved below the 200-day moving average on May 21, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.231) is normal, around the industry mean (24.191). P/E Ratio (27.625) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (1.648) is also within normal values, averaging (5.667). Dividend Yield (0.032) settles around the average of (0.018) among similar stocks. P/S Ratio (3.588) is also within normal values, averaging (42.393).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MDT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of medical technology services
Industry MedicalSpecialties